Perseus Biomics

Perseus Biomics is a Biotechnology, Health Care startup based in Belgium, dedicated to delivering more precise microbiome profiles at a faster pace. Founded in 2018, the company is driven by its slogan of 'Delivering more precise microbiome profiles, faster.' Perseus Biomics offers a unique solution through its DynaMAP technology, which empowers microbiome research, therapeutics, and personalized medicine with the ultimate aim of improving health. Recently, the company received a significant €2.50M grant investment on 16 June 2021 from the European Innovation Council. This investment is a clear indication of the confidence and support Perseus Biomics has garnered from prominent backers. The opportunity to combine state-of-the-art technology with the advancement of healthcare underscores the potential of Perseus Biomics as a strong contender in the biotech industry. Perseus Biomics' innovative approach has the potential to make a profound impact on microbiome analysis, offering researchers and clinicians the ability to perform precise, reproducible, and resource-efficient microbiome analysis both in laboratories and at point-of-need. Their commitment to leveraging technology for the betterment of health positions them as a compelling prospect worthy of attention within the startup and investment landscape.